![]() |
市場調查報告書
商品編碼
1679210
2030 年藻酸鹽敷料市場預測:按產品、材料、分銷管道、應用、最終用戶和地區進行的全球分析Alginate Dressings Market Forecasts to 2030 - Global Analysis By Product, Material, Distribution Channel, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球藻酸鹽敷料市場價值為 8.6 億美元,預計到 2030 年將達到 12.8 億美元,預測期內的複合年成長率為 6.2%。
海藻酸鹽敷料是由天然海藻中的海藻酸製成的先進創傷護理產品。這種吸收性極強的敷料在與傷口滲出液接觸時會形成凝膠狀物質,有效控制引流,同時創造一個濕潤的癒合環境。藻酸鹽敷料可減少細菌污染,促進自溶,且易於去除,不會對傷口床造成創傷。它們通常不粘連,需要二次敷料來牢固固定。
根據美國醫療保健研究和品質機構的數據,2% 至 4% 的住院患者會出現 SSI。
慢性傷口增多
糖尿病足潰瘍、壓瘡和靜脈性腿部潰瘍等慢性傷口的增加趨勢是藻酸鹽敷料發展的主要驅動力。全球糖尿病盛行率不斷上升、肥胖症以及人口老化也進一步加劇了對有效創傷護理產品的需求。此外,醫療保健基礎設施的進步和對最新傷口管理技術的日益認知正在推動藻酸鹽敷料的採用,從而推動全球市場的擴張。
傷口過度乾燥的風險
藻酸鹽敷料可以吸收多餘的滲出液並使傷口過度乾燥,導致傷口床乾燥和延遲癒合。對於低滲出液傷口來說,這尤其成問題,會導致組織脫水和不適。過度乾燥的風險限制了它的應用,並且使其不適合某些類型的傷口。此外,患者不滿意和因使用不當而導致的併發症進一步抑制了市場擴張。
創傷護理技術的進步
抗菌藻酸鹽敷料、提高吸收能力以及與銀或蜂蜜相結合的敷料等創新技術正在提高其在治療慢性和急性傷口方面的有效性。生物活性和智慧敷料的應用正在增加,特別是在治療糖尿病足部潰瘍、燒燙傷和手術傷口方面的需求不斷增加。此外,成本效益和環境友善的藻酸鹽敷料的開發正在支持市場擴張。隨著醫療保健系統優先考慮先進的傷口管理解決方案,技術進步繼續推動市場全球成長。
先進敷料高成本
藻酸鹽敷料價格昂貴,因為其具有來自海藻的先進創傷治療特性以及有效處理滲出液的能力。製造成本高,包括原料、加工等,是價格高的原因之一。此外,由於預算限制,醫療機構和患者可能不願意採用這些敷料,尤其是在低收入地區。高成本降低了可近性、降低了採用率並限制了成本敏感的醫療保健系統的需求,從而阻礙了市場成長。
COVID-19 疫情以多種方式影響了藻酸鹽敷料市場。雖然供應鏈中斷和醫院就診次數減少最初減緩了市場成長,但對 COVID-19 患者(尤其是住院時間較長的患者)創傷護理的關注度增加提振了需求。向家庭醫療保健和遠端醫療的轉變進一步刺激了對包括藻酸鹽敷料在內的先進創傷護理產品的需求,幫助市場在疫情後保持彈性。
預計海藻酸鈣敷料市場在預測期內將佔最大佔有率
預計預測期內海藻酸鈣敷料部分將佔據最大的市場佔有率。海藻酸鈣敷料是由海藻中的海藻酸纖維製成的先進創傷護理產品。這些吸水性極強的敷料能促進濕潤的癒合環境,並有助於自溶脫層。海藻酸鈣敷料有助於減少出血、降低感染風險並促進更快的組織再生。這些敷料需要二次敷料才能安全放置,並且可以輕鬆移除而不會造成創傷。
預計預測期內慢性傷口部分將以最高的複合年成長率成長。
預計預測期內慢性傷口部分將出現最高的成長率。藻酸鹽敷料對治療壓瘡、糖尿病足潰瘍和靜脈性腿部潰瘍等慢性傷口非常有效。該敷料由海藻中提取的藻酸鹽製成,與傷口滲出液接觸後會形成凝膠,保持濕潤的癒合環境並促進自溶剝落。它具有很強的吸收性,非常適合用於治療滲出液較多的傷口,降低浸漬風險。
在預測期內,由於中國、印度和日本等國家慢性傷口盛行率不斷上升、人口老化加劇以及糖尿病發病率不斷上升,預計亞太地區將佔據最大的市場佔有率。該市場的主要參與者包括KIMICA、山東潔晶集團、青島聚大洋藻業集團等。醫療保健基礎設施的改善和對先進創傷護理解決方案的認知不斷提高也促進了市場的擴大。
由於糖尿病潰瘍和壓瘡等慢性傷口的盛行率不斷上升以及人口老化,預計北美將在預測期內出現最高的複合年成長率。先進的醫療保健基礎設施和對創傷護理管理日益增強的認知促進了市場的成長。美國因醫療費用高昂且外科手術數量不斷增加而佔據主導地位。傷口敷料技術的進步以及對經濟高效的治療解決方案的需求進一步推動了其應用。
According to Stratistics MRC, the Global Alginate Dressings Market is accounted for $0.86 billion in 2024 and is expected to reach $1.28 billion by 2030 growing at a CAGR of 6.2% during the forecast period. Alginate dressings are advanced wound care products made from natural seaweed-derived alginic acid. These highly absorbent dressings form a gel-like consistency upon contact with wound exudate, creating a moist healing environment while effectively managing drainage. Alginate dressings help reduce bacterial contamination, promote autolytic debridement, and can be easily removed without causing trauma to the wound bed. They are typically non-adhesive and may require a secondary dressing for secure placement.
According to the Agency for Healthcare Research and Quality, SSIs occur in 2 to 4% of the total number of patients undergoing inpatient surgical procedures.
Rising prevalence of chronic wounds
The rising prevalence of chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, is a key driver of the alginate dressings. The increasing global incidence of diabetes, obesity, and aging populations further contributes to the growing demand for effective wound care products. Additionally, advancements in healthcare infrastructure and heightened awareness of modern wound management techniques propel the adoption of alginate dressings, driving market expansion worldwide.
Risk of over-drying wounds
Alginate dressings can over-dry wounds by absorbing excess exudate, potentially leading to desiccation of the wound bed and delayed healing. This is particularly problematic for wounds with minimal exudate, as it can cause tissue dehydration and discomfort. The risk of over-drying limits their applicability, making them unsuitable for certain wound types. Additionally, patient dissatisfaction and complications from improper use further restrain market expansion.
Advancements in wound care technologies
Innovations such as antimicrobial alginate dressings, improved absorption capacities, and combination dressings with silver or honey boost their efficacy in managing chronic and acute wounds. The rising adoption of bioactive and smart dressings accelerates demand, particularly in treating diabetic foot ulcers, burns, and surgical wounds. Additionally, the development of cost-effective and eco-friendly alginate dressings supports market expansion. As healthcare systems prioritize advanced wound management solutions, technological progress continues to propel the market's growth globally.
High cost of advanced dressings
Alginate dressings are costly due to their advanced wound-healing properties, derived from seaweed, and their ability to manage exudate efficiently. The high production costs, including raw materials and processing, contribute to their expensive pricing. Additionally, healthcare facilities and patients may hesitate to adopt these dressings due to budget constraints, especially in low-income regions. The high cost hampers market growth by reducing accessibility, slowing adoption rates, and restricting demand in cost-sensitive healthcare systems.
The covid-19 pandemic had a mixed impact on the alginate dressings market. While disruptions in the supply chain and reduced hospital visits initially slowed market growth, the increased focus on wound care for covid-19 patients, especially those with prolonged hospital stays, boosted demand. The shift towards home healthcare and telemedicine further increased the demand for advanced wound care products, including alginate dressings, ensuring continued market resilience post-pandemic.
The calcium alginate dressings segment is expected to be the largest during the forecast period
The calcium alginate dressings segment is expected to account for the largest market share during the forecast period. Calcium alginate dressings are advanced wound care products made from seaweed-derived alginate fibers. These highly absorbent dressings promote a moist healing environment and aiding in autolytic debridement. Calcium alginate dressings help control bleeding, reduce infection risk, and support faster tissue regeneration. They require secondary dressings for secure placement and are easy to remove without causing trauma.
The chronic wounds segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the chronic wounds segment is predicted to witness the highest growth rate. Alginate dressings are highly effective for managing chronic wounds, such as pressure ulcers, diabetic foot ulcers, and venous leg ulcers. Made from seaweed-derived alginic acid, these dressings form a gel when in contact with wound exudate, maintaining a moist healing environment and promoting autolytic debridement. Their high absorbency makes them ideal for heavily exuding wounds, reducing the risk of maceration.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to increasing prevalence of chronic wounds, a growing aging population, and a rising incidence of diabetes in countries like China, India, and Japan. Key players in this market include KIMICA, Shandong Jiejing Group, and Qingdao Gather Great Ocean Algae Industry Group. Improving healthcare infrastructure and greater awareness of advanced wound care solutions further contribute to market expansion.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by the rising prevalence of chronic wounds, such as diabetic ulcers and pressure sores, along with an aging population. Advanced healthcare infrastructure and growing awareness of wound care management contribute to market growth. The U.S. dominates due to high healthcare spending and increasing surgical procedures. Technological advancements in wound dressings, along with the demand for cost-effective and efficient healing solutions, further boost adoption.
Key players in the market
Some of the key players in Alginate Dressings market include 3M, Advanced Medical Solutions Limited, B. Braun Melsungen AG, BSN medical GmbH, Cardinal Health, Coloplast A/S, Convatec Inc., Hollister Inc., Medline Industries, Inc., Molnlycke Health Care, Paul Hartmann AG, Roosin Medical Co., Ltd., Smith & Nephew Plc, Boryung Corporation and KCI Medical.
In February 2025, Boryung has introduced a new line of customized Liquidem dressings specifically designed to address various winter-related wounds. These advanced dressings aim to provide effective treatment and protection against common winter skin issues, such as dryness-induced cracks, frostbite, and other cold-related injuries. By tailoring their products to meet the unique challenges posed by colder weather, Boryung seeks to enhance wound care and promote faster healing during the winter season.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.